4 million of Americans with celiac disease dont realize it 1 Roughly.

David Malek as our fresh Vice President of Business Advancement. David joins us from Sanofi, where he offered as Director of Oncology – SERVICES and Business Development. We welcome David to your team, and look forwards to his contributions.’ Highlights of the next one fourth of 2011: BL-1020: IN-MAY, BioLineRx announced that it reacquired the advancement and commercialization privileges in THE UNITED STATES of BL-1020, for treatment of schizophrenia, from Cypress Bioscience Inc.and reMYND NV today announced the signing of a partnership contract to offer the Amorfix A4 amyloid screening service to reMYND’s agreement research clients. ReMYND’s contract research business provides an comprehensive portfolio of preclinical in-vivo efficacy, pharmacokinetic and safety tests of experimental Alzheimer therapies using proprietary mouse types of Alzheimer’s disease . ‘We are pleased to be dealing with reMYND to provide our A4 services to their clients, together providing a comprehensive remedy to assess efficacy of medication candidates for treating AD using their proprietary versions,’ said Vigen Nazarian, Vice President of Strategic Alliances for Amorfix.

Related Posts

Other Posts From Category "health":